ADVERTISEMENT
ADVERTISEMENT
Latent Health raises $80M to expand clinical AI deployment
The startup has expanded from four to more than 45 health-system partners in the past year.
-
1759163132.png)
Anushka Pathak - Fri, 20, Mar 2026
- 12:24 EDT
- 16
Latent Health has raised US $80 million in Series A funding / Courtesy: LinkedIn/Latent Health
San Francisco-based clinical AI startup Latent Health has raised US $80 million in Series A funding to streamline medication access and reduce delays between diagnosis and treatment across the United States.
The company, founded in 2022 by Indian-American entrepreneurs Rishabh Jain and Sriram Somasundaram, now works with half of the top 20 U.S. health systems.
ALSO READ: Cometchat gets $6.5M to boost AI strategy
Its platform automates prior authorizations and related workflows using a clinical reasoning engine that analyzes patient records, interprets drug requirements, extracts clinical evidence, and coordinates processes across healthcare stakeholders, replacing manual systems that often delay therapy.
L-R: Rishabh Jain and Sriram Somasundaram, co-founders of Latent Health / Courtesy: LinkedInThe company has expanded from four to more than 45 health-system partners in the past year, including Yale New Haven Health, Ochsner Health, and MetroHealth. More than 2 million patients have accessed medications faster through its platform.
Health systems reported measurable improvements, including a 50 percent reduction in reauthorization timelines, enabling completion within the same month.
At Ochsner Health, prior-authorization review times dropped to four to five minutes, about 75 percent faster than industry benchmarks. Across specialties, denial rates declined by more than 30 percent, while clinicians were able to serve twice as many patients.
The company said advances in medicine have outpaced the systems used to deliver care and positions its platform as a way to close the gap between clinical decisions and therapy initiation through AI-driven workflows.
Latent Health, part of Y Combinator’s Winter 2023 batch, employs about 50 people and maintains a three-year design partnership with Ochsner Health, initiated in Nov. 2023, to develop clinical AI tools for prior authorizations across specialties.
The company plans to use the new funding to expand its partnerships with health systems, deepen integrations across healthcare networks, and scale its platform and team.
The funding round was co-led by Spark Capital and Transformation Capital, with participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator.
Discover more at New India Abroad.
Related
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login